Managing data to understand cancer treatment resistance
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
This study is bringing together experts to share important information about why some cancer treatments don't work, with the goal of finding better ways to help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10911880 on NIH RePORTER |
What this research studies
This research focuses on coordinating and managing data related to cancer treatment resistance through a network of experts. By integrating and disseminating valuable information, the project aims to enhance collaboration among researchers and improve strategies to overcome challenges in cancer therapies. Patients may benefit from the development of new treatment approaches informed by comprehensive data analysis and shared resources. The research employs a multi-disciplinary approach to ensure that findings are reproducible and accessible to the broader scientific community.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing cancer treatment who are experiencing or at risk of developing resistance to therapies.
Not a fit: Patients with cancers that are not currently being studied within the Acquired Resistance to Therapy Network may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment strategies that effectively address drug resistance.
How similar studies have performed: Previous research has shown success in collaborative data management approaches to tackle complex issues in cancer treatment, indicating that this methodology is promising.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.